Floatz logo

Therapeutic Asset Ratings

171 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Palonosetron
Chemotherapy-induced Nausea and Vomiting
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP4A (82)
Acetylsalicylic Acid
Brain Infarction
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP4BBB (75)
Phosphonic acid, P-[3-[[(2R,3R)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-2,5-dihydro-5-oxo-1H-1,2,4-triazol-1-yl]-
Chemotherapy-induced Nausea and Vomiting
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP4BBB (75)
Selinexor
DLBCL
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP4BBB (72)
LECANEMAB
Alzheimer's Disease
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP4BB (71)
17-ALLYL-4,5A-EPOXY-3,14-DIHYDROXYMORPHINAN-6-ONE
Chronic Pain
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP4BB (70)
Cyclophosphamide
Breast Adenocarcinoma
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP3BB (70)
Evomela
Lymphoma
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP4BB (67)
Compound Edaravone
Stroke
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP4BB (66)
Cyclophosphamide
Primary Peritoneal Carcinoma
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP3BB (66)
DEXAMETHASONE
Nausea and Vomiting Caused by Chemotherapy
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP3BB (66)
LECANEMAB
Alzheimer Disease (AD)
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP4BB (65)
Tenecteplase
Cerebral Infarction
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP3BB (65)
Eloxatin
Cancer of Colon
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP2BB (65)
Epirubicin
Breast Adenocarcinoma
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP2BB (65)
Nivolumab
Recurrent Central Nervous System Lymphoma
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP2BB (65)
Nivolumab
Refractory Central Nervous System Lymphoma
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP2BB (65)
Eloxatin
Colorectal Cancer Metastatic
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP4BB (64)
Recombinant Human Plasminogen Activator
Acute Ischemic Stroke (AIS)
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP4BB (64)
Recombinant Human Plasminogen Activator
Thrombosis
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP4BB (64)
Cyclophosphamide
Fallopian Tube Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP3BB (64)
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
ER Positive, HER2 Positive Breast Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP2BB (64)
Catequentinib
Ovarian Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP4B (63)
Recombinant Human Plasminogen Activator
Anterior Circulation Brain Infarction
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP3B (63)
Inno-206
Efficacy
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP4B (62)
Showing 1 to 25 of 171 assets
PreviousPage 1 of 7Next